Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Trial of Combination Immunotherapy in Subjects With Advanced HPV Associated Malignancies

NCT04287868 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT04287868
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04287868 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Trial of Combination Immunotherapy in Subjects With Advanced HPV Associated Malignancies
Lead sponsor
National Cancer Institute (NCI)
Phase
Phase 1/2
Overall status
Completed
Start date
June 9, 2020
Completion date
May 14, 2026
Enrollment
51 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anal cancer, cervical cancer, hpv cancers, oropharyngeal cancer, vulvar, vaginal, penile, rectal cancer